News 
Market Data 
Discover
Replies to post #59740 on Muscle Pharm Corporation (MSLPQ)
10/02/13 1:59 AM
Unless we indicate otherwise, all information in this prospectus:
· is based on 8,823,623 shares of common stock issued and outstanding as of August 19, 2013 ;
· excludes the conversion of the Company’s Series D Preferred Stock into an aggregate of 290,000 shares of common stock;
· excludes 1,550,000 shares of shares of restricted common stock that was awarded to certain named executive officers, directors and employees of the Company which are subject to vesting;
· excludes 670 shares of our common stock issuable upon exercise of outstanding options at a weighted average exercise price of $425.00 per share as of August 19, 2013; and
· excludes 1,636,276 shares of common stock issuable upon vesting and settlement of outstanding restricted stock unit awards as of August 19, 2013.
10/02/13 2:04 AM
10/02/13 2:07 AM
10/02/13 2:19 AM
Percent of class based on 8,823,623 shares of common stock outstanding as of August 19, 2013.
Officers and Directors as a Group (nine persons): 409,083 4.64 % 51 100 % 53.27 %
Officers and Directors as a Group (nine persons): 409,083 4.64 %
Marine MP, LLC (5) 780,000 8.84 %
10/02/13 2:25 AM
10/02/13 2:37 AM
As of August 13, 2013, there were 10,127,124 shares outstanding of the registrant’s common stock.
10/02/13 2:43 AM
